Drug Synthesis Services for Methamphetamine-mediated pharmacology and behaviors

The VA Office of Research and Development, Portland VA Medical Center Research Department intends to negotiate on a sole source basis with Organix, Inc. pursuant to FAR 6.302-1; for drug synthesis services. The production of these drugs will allow identification of the role of targets in Methamphetamine-mediated pharmacology and behaviors, and will characterize potential new synthesized pharmacotherapies that can be used to treat specific symptoms of Methamphetamine abuse and addiction. This contract will be a continuation of services provided by Organix Inc. involving proprietary data.



This notice of intent is not a request for competitive proposals, however; any responsible source who believes it is capable of meeting the requirement may submit a capability statement to the contracting office no later than April 7, 2016 (4:00PM, EST). Interest/capability statements may be sent to Travis Gibbons at travis.gibbons@va.gov. No telephone responses will be accepted. A determination not to compete the proposed requirement based upon the responses to this notice is solely within the discretion of the Government.